MSB 2.10% $1.17 mesoblast limited

Ann: Trading halt, page-151

  1. 49 Posts.
    lightbulb Created with Sketch. 107
    On reflection I don't think it is a takeover attempt as all the pharmaceutical companies would probably have signed ndas . Unless Novartis asks the board to consider something . I think the most likely scenario is negotiations with the fda regarding the ARDS trial . In my opinion .the recruitment for the 60percent was reached end October. This has given the data monitoring committee masses of time to opine on efficacy I suspect that has then led to a discussion with the fda and we are now in the hard yards as to what exactly the deal will be . The next couple of days are the details regarding emergency use , pricing , further trials etc . Just a thought . Hopefully right ! I think a sensitive part of the shorts anatomies are twitching right now !
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.